Titlebook: Contemporary Pharmacotherapy of Overactive Bladder; Lindsey Cox,Eric S. Rovner Book 2019 Springer Nature Switzerland AG 2019 voiding dysfu

Perforation

書目名稱Contemporary Pharmacotherapy of Overactive Bladder影響因子(影響力)




書目名稱Contemporary Pharmacotherapy of Overactive Bladder影響因子(影響力)學(xué)科排名




書目名稱Contemporary Pharmacotherapy of Overactive Bladder網(wǎng)絡(luò)公開度




書目名稱Contemporary Pharmacotherapy of Overactive Bladder網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Contemporary Pharmacotherapy of Overactive Bladder被引頻次




書目名稱Contemporary Pharmacotherapy of Overactive Bladder被引頻次學(xué)科排名




書目名稱Contemporary Pharmacotherapy of Overactive Bladder年度引用




書目名稱Contemporary Pharmacotherapy of Overactive Bladder年度引用學(xué)科排名




書目名稱Contemporary Pharmacotherapy of Overactive Bladder讀者反饋




書目名稱Contemporary Pharmacotherapy of Overactive Bladder讀者反饋學(xué)科排名

BORE

Diagnosis of Overactive Bladder,ne the condition as it has evolved over the past few decades. We will then review the basis for establishing a diagnosis, which includes a thorough symptom assessment as well as physical exam and urine studies. The use of adjunctive tests will also be reviewed, although their utility is limited in t

貴族

The Placebo Effect in Overactive Bladder Syndrome,ases and conditions. Some of the popular theories explaining the placebo effect are a “regression to the mean,” “expectancy theory,” “classical conditioning” theory, “context effect,” “meaning response,” and learned response theory. The effect of placebo in overactive bladder syndrome (OAB) has been

彩色

廚師

National and International Guidelines for Overactive Bladder,atrics, neurology, gynecology, and urology, are involved in the diagnosis and management of a wide range of patients who present with symptoms of OAB. Several urologic, urogynecologic, geriatric societies and other organizations have developed guidelines for the evaluation and pharmacologic treatmen

后退

Antimuscarinic Pharmacotherapy for Overactive Bladder, by acetylcholine, which is released from cholinergic parasympathetic nerves. Antimuscarinic agents work during the storage phase of the micturition cycle to reduce involuntary bladder contractions and the sensation of urgency. A variety of antimuscarinics are available for use in the treatment of o

后退

,β3-Agonists for Overactive Bladder,tients, efficacy is not seen in all, and the side effect profile may result in decreased use. Mirabegron, a β3-adrenoceptor agonist, has been established as an alternative therapy. This chapter aims to review the history of mirabegron in addition to drug safety, efficacy, and reliability in a divers

細(xì)節(jié)

在駕駛

Friction

Pharmacotherapy for Nocturia,ssion of the indications and efficacy of different classes of medications used to treat nocturia. Nocturia, defined as voiding that occurs during the hours of sleep, is common and bothersome. The underlying causes are multiple and diverse. Determining the underlying etiology is essential for choosin